Jianqin Lu
Affiliations: | School of Pharmacy | University of Pittsburgh, Pittsburgh, PA, United States | |
| 2019- | University of Arizona, Tucson, AZ |
Area:
Drug Delivery and NanomedicineWebsite:
https://jianqinlu.wixsite.com/jianqinluGoogle:
"https://scholar.google.com/citations?user=Xlj9fDwAAAAJ&hl=en"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Nicholas Little | grad student | 2020- | University of Arizona |
| Wenpan Li | post-doc | 2019- | University of Arizona |
| Zhiren Wang | post-doc | 2019- | University of Arizona |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Z, Li W, Jiang Y, et al. (2023) Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature Communications. 14: 7235 |
| Wang Z, Gonzalez KM, Cordova LE, et al. (2023) Nanotechnology-empowered therapeutics targeting neurodegenerative diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1907 |
| Jiang T, Gonzalez KM, Cordova LE, et al. (2023) Nanotechnology-enabled gene delivery for cancer and other genetic diseases. Expert Opinion On Drug Delivery. 1-18 |
| Li W, Jiang Y, Lu J. (2023) Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy. International Journal of Pharmaceutics. 122655 |
| Wang Z, Cordova LE, Chalasani P, et al. (2022) Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy. Molecular Pharmaceutics. 19: 4665-4674 |
| Li W, Gonzalez KM, Chung J, et al. (2022) Surface-modified nanotherapeutics targeting atherosclerosis. Biomaterials Science |
| Wang Z, Li W, Park J, et al. (2022) Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 929-939 |
| Wang Z, Little N, Chen J, et al. (2021) Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nature Nanotechnology |
| Li W, Little N, Park J, et al. (2021) Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Molecular Pharmaceutics |
| Wang Z, Chen J, Little N, et al. (2020) Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. Acta Biomaterialia |